Crossmark

Real-life effects of adding weekly subcutaneous semaglutide to insulin for the treatment of type 2 diabetes mellitus

Crossref DOI link: https://doi.org/10.1016/j.rceng.2022.06.001

Published Print: 2022-11

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Ares-Blanco, J.

Pujante-Alarcón, P.

Lambert, C.

Morales-Sánchez, P.

Delgado-Álvarez, E.

Menéndez-Torre, E.L.
License Information

Text and Data Mining valid from 2022-11-01
More Information

This article is maintained by: Elsevier

Article Title: Real-life effects of adding weekly subcutaneous semaglutide to insulin for the treatment of type 2 diabetes mellitus

Journal Title: Revista Clínica Española (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.rceng.2022.06.001

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.rce.2022.03.009

Content Type: article

Copyright: © 2022 Elsevier España, S.L.U. and Sociedad Española de Medicina Interna (SEMI). All rights reserved.